Amy Ziober
Papers
1
Total Citations
45
H-Index
1
About
Dr. Amy Ziober is a leading surgical pathologist whose research focuses on the molecular characterization of head and neck cancers, particularly oropharyngeal squamous cell carcinomas (OPSCC). Her most influential work, a 2011 study with 45 citations, was pivotal in demonstrating how p16<sup>INK4a</sup> immunohistochemistry serves as a critical prognostic biomarker for treatment outcomes in patients undergoing transoral robotic surgery and adjuvant therapy. By correlating p16 status with survival rates in a prospective cohort, Dr. Ziober helped establish that p16-positive tumors respond more favorably to combined surgical and adjuvant regimens, directly influencing clinical decision-making for de-escalation protocols. Her contributions bridge the gap between histopathology and personalized oncology, providing surgeons and oncologists with actionable data to tailor aggressive treatments. Through her meticulous retrospective evaluations of prospective trials, Dr. Ziober has advanced the understanding of how viral-driven cancers differ from traditional carcinogen-induced malignancies. Her work remains a cornerstone for researchers exploring biomarker-guided therapies, earning her recognition as a key figure in the evolution of precision medicine for head and neck oncology.
Research Focus
Key Achievements
Top Papers
- 1